Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica D Lang

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scientific Reports|May 25, 2021
Improved methods for RNAseq-based alternative splicing analysisRebecca F Halperin, Apurva Hegde, Jessica D Lang, et al.
Cancers|July 12, 2025
MYC Regulates a DNA Repair Gene Expression Program in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeJames R Evans, Jing Wang, Cinthia N Reed, et al.
Biomarker Research|July 25, 2023
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxelJessica D Lang, Tuong Vi V Nguyen, Maren K Levin, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaquesOlivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
Plos Pathogens|September 25, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infectionOlivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics|September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeYemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Med (New York, N.Y.)|July 5, 2021
Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancerJonathan M Ghergurovich, Jessica D Lang, Maren K Levin, et al.
Iscience|February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic typeJessica D Lang, William Selleck, Shawn Striker, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|May 25, 2021
Improved methods for RNAseq-based alternative splicing analysisRebecca F Halperin, Apurva Hegde, Jessica D Lang, et al.
Cancers|July 12, 2025
MYC Regulates a DNA Repair Gene Expression Program in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeJames R Evans, Jing Wang, Cinthia N Reed, et al.
Biomarker Research|July 25, 2023
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxelJessica D Lang, Tuong Vi V Nguyen, Maren K Levin, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaquesOlivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
Plos Pathogens|September 25, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infectionOlivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics|September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeYemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Med (New York, N.Y.)|July 5, 2021
Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancerJonathan M Ghergurovich, Jessica D Lang, Maren K Levin, et al.
Iscience|February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic typeJessica D Lang, William Selleck, Shawn Striker, et al.
Pageof 3